thromboplastin and Carcinoma--Endometrioid

thromboplastin has been researched along with Carcinoma--Endometrioid* in 1 studies

Other Studies

1 other study(ies) available for thromboplastin and Carcinoma--Endometrioid

ArticleYear
Tissue factor expression and tumor-infiltrating T lymphocytes in ovarian carcinomas and their association with venous thromboembolism.
    Pathology international, 2021, Volume: 71, Issue:4

    Ovarian cancer is a known risk factor of venous thromboembolism (VTE). Thrombogenic factor expression and lymphocytic infiltrate have been reported in endometriosis and ovarian cancers. We reviewed 30 cases of ovarian carcinomas (high grade serous carcinoma, 10; endometrioid carcinoma, 10; clear cell carcinoma (CCC), 10) and 16 endometriotic lesions. We immunohistochemically investigated the expressions of tissue factor (TF), podoplanin, P-selectin, and number of CD4 and CD8 positive lymphocytes in cancer tissue and endometriotic lesions, along with their relationship with VTE. The expression of TF was higher in CCC. The TF expression and the number of CD8 positive cells were higher in cancer tissues with VTE than in those without VTE. The podoplanin or P-selectin expression did not differ among histological types or between cases with and without VTE. Our results demonstrated a high TF expression and intraepithelial CD8 cells in CCC, which were associated with VTE. The results suggest that infiltrating lymphocytes may affect TF expression that, in turn, influences VTE.

    Topics: Adenocarcinoma, Clear Cell; Aged; Carcinoma, Endometrioid; CD8-Positive T-Lymphocytes; Female; Humans; Lymphocytes, Tumor-Infiltrating; Membrane Glycoproteins; Middle Aged; Ovarian Neoplasms; P-Selectin; Thromboplastin; Thrombosis; Venous Thromboembolism

2021